Related Experiment Videos
Fructosamine monitoring in patients with diabetes: is there a need?
1National Diabetes Laboratory, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. loh2@cdc.gov
Diabetes Technology & Therapeutics
|July 28, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transcriptional profiling of the L. monocytogenes PrfA regulon identifies six novel putative PrfA-regulated genes.
FEMS microbiology letters·2020
Quantitative fluorescence cytometry.
Methods in molecular medicine·2011
Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.
Cytometry. Part B, Clinical cytometry·2010
Factors Associated with Utilization and Underutilization of Diabetes Technology in Underrepresented Families Living with Type 1 Diabetes.
Diabetes technology & therapeutics·2026
Continuous Glucose Monitoring and Hospitalization Outcomes in Adults with Insulin-Treated Type 2 Diabetes and Complex Care Needs: A Population-Based Study.
Diabetes technology & therapeutics·2026
Three-Year Real-World Performance of Bihormonal Fully Closed-Loop Therapy in Type 1 Diabetes.
Diabetes technology & therapeutics·2026
Sustained Glycemic Outcomes with the MiniMed™ 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years.
Diabetes technology & therapeutics·2026
Adaptation to a Lower Protein Diet Before Reproduction Trades off with Immunocompetence and the Ability to Survive Pathogenic Infections.
Evolution; international journal of organic evolution·2026
Trimester-specific associations of methyl-donor nutrients and prenatal dietary patterns with adolescent blood leukocyte circadian gene DNA methylation.
Journal of developmental origins of health and disease·2026